ELLIS EARL RAY 4

What Happened

• Ellis Earl Ray, a director of Xylem Inc., was granted 1,711 restricted stock units (RSUs) on 2026-05-14 at an implied value of $116.88 per share, totaling approximately $199,982. This filing reports an award (not a purchase or sale).

Key Details

• Transaction date and terms: 1,711 RSUs granted on 2026-05-14 at $116.88 per share (total ~$199,982).
• Vesting and settlement: RSUs are scheduled to vest in full on the trading day prior to Xylem’s 2027 Annual Meeting of Shareholders. The reporting person elected to defer settlement of the award until Separation of Service.
• Plan and notes: Award granted under the Xylem 2011 Omnibus Incentive Plan (as amended Feb 24, 2016). The reported amount includes additional shares due to dividend reinvestment (per filing footnote).
• Shares owned after transaction: Not specified in this Form 4.
• Filing timeliness: Form 4 was filed 2026-05-15 for a 2026-05-14 transaction—no late filing indicated.

Context

• RSUs are compensation awards that convert to shares (or cash) upon vesting; this grant is a routine equity compensation action rather than an open-market purchase or sale. Because settlement is deferred until separation, the director will not receive shares immediately upon vesting.